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Background. The 2014 US Surgeon General’s report noted research gaps necessary to determine 
a causal relationship between active cigarette smoking and invasive breast cancer risk, including 
the role of alcohol consumption, timing of exposure, modification by menopausal status, and 
heterogeneity by estrogen receptor (ER) status.  
Methods. To address these issues, we pooled data from 14 cohort studies contributing 934 681 
participants (36 060 invasive breast cancer cases). Cox proportional hazard regression models 
were used to calculate multivariable-adjusted hazard ratios (HR) and 95% confidence intervals 
(CI).  
Results. Smoking duration before first birth was positively associated with risk (p-value for 
trend=2x10-7) with the highest HR for initiation >10 years before first birth (HR=1.18, CI 1.12–
1.24). Effect modification by current alcohol consumption was evident for the association with 
smoking duration before first birth (p-value=2x10-4); compared to never smoking non-drinkers, 
initiation >10 years before first birth was associated with risk in every category of alcohol intake, 
including non-drinkers (HR=1.15, CI 1.04–1.28) and those who consumed ≥3 drinks per day 
(1.85, 1.55–2.21). Associations with smoking before first birth were limited to risk of ER+ breast 
cancer (p-value for homogeneity=3x10-3). Other smoking characteristics were associated with 
risk even after controlling for alcohol, but were not associated with risk in non-drinkers. Effect 
modification by menopause was not evident.  
Conclusions. Smoking, particularly if initiated before first birth, was modestly associated with 
ER+ breast cancer risk that was independent of adult alcohol intake. Possible links with breast 
cancer provide additional motivation for young women to not initiate smoking. 
 




 In a pooled analysis of 14 prospective cohort studies of nearly one million women, smoking 
>10 years before first birth had the strongest association with breast cancer risk of all the 
smoking characteristics.  
 
 The association with smoking >10 years before first birth varied by alcohol consumption, 
but was evident in every category of alcohol intake.  
 
 Associations with smoking characteristics, including those with smoking initiation, were 
stronger for risk of ER+ breast cancer. 
 
 The association of smoking characteristics with breast cancer risk varied little by 





Determining whether there is a causal relationship between active cigarette smoking and breast 
cancer risk has been controversial. Strong biological data linking active smoking, particularly at 
young ages, with breast carcinogenesis, include the induction of mammary cancers by 20 
tobacco smoke compounds in rodents 1-3 and detectable tobacco metabolites 4, 5 and smoking-
specific DNA adducts and p53 mutation in human breasts6-10. Despite the biological data and the 
large number of epidemiologic studies 1, 2, 11-16 , the recent U.S. Surgeon General’s report 
concluded that “the evidence is suggestive but not sufficient to infer a causal relationship 
between active smoking and breast cancer 11.” The report noted lingering epidemiological issues 
concerning the assessment of this relationship, including whether the association is due to: (a.) 
the timing of exposure at early ages and/or long duration of smoking, (b.) confounding or effect 
modification by alcohol intake, (c.) modification by menopausal status, or (d.) differences by 
estrogen receptor (ER) status.   
 
The two prevailing concerns are residual confounding by alcohol intake and timing of smoking 
initiation relative to first birth 1, 2, 11-16. Alcohol consumption is an established risk factor for 
breast cancer; even consumption at low levels is associated with increased risk 17. Some have 
argued that the association with active smoking can only be evaluated in never drinkers, because 
of the potential correlation between cigarette smoking and alcohol consumption18. The 
Collaborative Group on Hormonal Factors in Breast Cancer 18 concluded that there was no 
association of ever smoking (relative risk (RR)=1.03); however, among drinkers, the RR with 
ever smoking was 1.09, which was attenuated to 1.05 after adjustment for amount of alcohol 
consumed 18. Analysis of smoking initiation relative to first birth is also an important issue 
because before the first full-term birth the undifferentiated breast epithelium is particularly 
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susceptible to carcinogens 19. While previous studies have shown that the strongest smoking 
association with breast cancer risk is among women who initiated smoking prior to first birth 20, 
21, no studies have examined associations of initiation relative to first birth stratified by alcohol 
consumption.   
 
In this study, we pooled data from 14 prospective cohorts and undertook a unified analytical 
approach to overcome the lingering epidemiological issues related to assessing the association 
between smoking and breast cancer risk.  
 
METHODS 
Study Population.  Member studies of the National Cancer Institute (NCI) Cohort Consortium 
with smoking data and ≥500 incident breast cancer cases were invited to participate; 14 cohorts 
(Supplemental Table 1) agreed. Investigators from each cohort provided individual-level data for 
the entire cohort after excluding those who were male, had a personal history of cancer at 
baseline (except non-melanoma skin cancer), had missing information on smoking status at 
baseline, or had other cohort-specific exclusions. Data for 934,681 women were included in this 
analysis. Written informed consent was obtained from study participants at entry into each cohort 
or was implied by participants’ return of the enrollment questionnaire. The present investigation 
was approved by the Institutional Review Board (IRB) at each participating institution or was 
considered within the scope of the original IRB protocol.  
 
Exposure Information. De-identified data from the baseline questionnaire were provided for 
active cigarette smoking, current alcohol consumption (former alcohol drinkers were 
distinguished for only 6 of 14 studies), and other characteristics. Smoking status (never, former, 
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current) is defined as at the time the baseline questionnaire was completed. Data were 
harmonized and variables were categorized a priori. Initiation of smoking relative to first birth, 
defined among parous women, is based on the number of years between age at smoking initiation 
and age at first pregnancy. 
 
Case Definition. In our primary analyses, cases were defined as incident, invasive breast cancers 
diagnosed after enrollment and identified through self-report, cancer registry linkage, medical 
record/pathology report, or death certificate. In the latter situation, breast cancer had to be listed 
as a primary or contributory cause of death (ICD-9: 174 or ICD-O, ICD-10: C50). Incident in 
situ breast tumors were excluded from the case definition, because risk factors for in situ breast 
cancer might differ from invasive breast cancer 22. Tumors of unknown invasiveness were 
assumed to be invasive.  
 
Statistical Analysis. Person-time was calculated from the date of the return of the baseline survey 
until the date of the first-occurring event: breast cancer diagnosis, death, or last follow-up. 
Women diagnosed with carcinoma in situ of the breast were censored at the time of diagnosis. In 
pooled analyses, Cox proportional hazard regression models were used to calculate minimally-
adjusted and multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (CI). All 
models controlled for study as a covariate and were stratified on age at enrollment. 
Multivariable-adjusted models included breast cancer risk factors (listed in Table 1), and are 
shown with and without control for alcohol consumption. Models of time since quitting also 
included smoking duration. Linear trends with continuous smoking variables were evaluated 
excluding never smokers. In addition to pooled analyses, a meta-analytic approach was used 
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assuming a random effects model and weighting the cohorts based on the inverse of the cohort 
size. Between-study heterogeneity was assessed using the I2 statistic. 
 
Interaction analyses were conducted using a common reference group to evaluate for effect 
modification on the multiplicative scale. A p-value for interaction was calculated comparing the -
2 log likelihood estimates of models with and without the interaction term(s). The interaction 
term was the cross-product of the two categorical variables with missing values excluded. 
Associations were evaluated for subgroups defined by ER status using a joint Cox proportional 
hazards model 23. Since data on ER status were not available for all cases, we compared main 
effect associations using cases with and without ER status to ensure those with data were not a 
biased sample. In sensitivity analysis, the influence of changes in smoking patterns prior to 
breast cancer diagnosis were examined by excluding cases that were diagnosed within the first 
two years of follow-up; this exclusion did not appreciably alter associations (data not shown). 
Reported p-values are two-sided. Analyses were performed in SAS (version 9.4). 
 
RESULTS 
Among 934 681 study participants, 36 060 invasive breast cancer cases were diagnosed. The 
average age at baseline was 53.9 years, age at first birth was 24.0 years, and number of births 
was 2.5. Most women were white (91.8%), had at least some college education (62.1%), and 
were postmenopausal at baseline (60.3%). Current smokers at baseline accounted for 16.2% of 
participants and they smoked an average of 15.3 cigarettes per day. Former smokers accounted 
for 30.9% of the participants and they quit smoking, on average, at 37.7 years of age. Most 
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smokers (73.9%) started smoking before their first birth. Parous smokers who started before first 
birth, compared to those who started after first birth, were more likely to have smoked for longer 
(mean 23 vs. 20 years, p-value <1x10-3), and to have had their first birth at an older age (mean 24 
vs. 21 years of age, p-value <1x10-3). Known breast cancer risk factors had expected associations 
(Supplemental Table 2). 
Current smokers were more likely than never smokers to be less educated, premenopausal, 
current alcohol drinkers, oral contraceptive users, never users of menopausal hormone therapy, 
and have a lower BMI (Table 1). Former smokers were more likely to have used menopausal 
hormone therapy than never smokers. Current and former smokers were more likely to drink 
alcohol at baseline than never smokers. 
There was little confounding of the association between smoking status and invasive breast 
cancer (Table 2): controlling for alcohol intake at baseline changed the HR for current smoking 
from 1.09 to 1.07 (95% CI 1.04 – 1.10), compared to never smokers. There was no evidence of 
between-study heterogeneity (Supplemental Figure 1). Associations of other characteristics of 
smoking showed linear trends (p-values<1x10-3; Table 2); however, categorical HRs were within 
a narrow range of values (e.g., HRs for duration in current smokers ranged from 1.01 – 1.11). 
Smoking 40 or more cigarettes per day at baseline had the strongest association with risk of 
breast cancer (HR=1.17, 95% CI 1.05 – 1.31; p for trend=4x10-3).  
In parous women, those who initiated smoking more than 10 years before their first birth had the 
highest risk of breast cancer, compared to never smokers (HR=1.18, 95% CI 1.12 – 1.24; Table 
2). Results for smoking before first birth did not vary by study (Supplemental Figure 2). To 
evaluate whether this association was driven by residual confounding from later age at first birth 
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or longer smoking duration, we conducted stratified analyses by these factors and found similar 
effects for smoking initiation in each strata (p-value for interaction=0.51 and 0.74, respectively; 
Supplemental Table 3a and 3b).  
Smoking patterns differed by current alcohol consumption (results not otherwise shown): among 
non-drinkers, 68% women were never smokers, 12% were current smokers, and 20% were 
former smokers. Among people who drank >2 drinks/day, 28% were never smokers, 33% were 
current smokers, and 39% were former smokers. Smoking ≥40 years was more prevalent among 
women who reported drinking >2 drinks per day than not currently drinking, 11.5% vs. 4.1% 
respectively. 
The associations of smoking characteristics with breast cancer risk were modified by current 
alcohol intake (p-values for interaction<0.05; Table 3). Using a common reference group of 
never smokers, non-drinkers, former and current smoking was not associated with breast cancer 
risk among non-drinkers; however, current drinkers consuming two or more drinks per day who 
were former (HR=1.33, 95% CI 1.19 – 1.49) or current smokers (HR=1.32, 95% CI 1.16 – 1.49) 
were at slightly greater risk than expected under a multiplicative model (expected HRs=1.22 and 
1.23, respectively).  Smoking more than 10 years before first birth was associated with breast 
cancer risk among non-drinkers (HR=1.15, 95% CI 1.04 – 1.28) and in every stratum of alcohol 
intake (Table 3). Current drinkers consuming ≥3 drinks per day who smoked >10 years prior to 
first birth (HR=1.85, 95% CI 1.55 – 2.21; Table 3) were at noticeably greater risk than expected 
under a multiplicative model (expected HR=1.37).  
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Interactions with menopausal status and age at menopause were also examined (Table 4). The 
associations with smoking status and smoking initiation relative to first birth did not 
meaningfully vary by menopause status and age at menopause.  
 
We also examined whether the association with smoking status was different for subtypes 
defined by ER status (Table 5). Most breast cancers were ER+ (67.4%); the association of 
smoking characteristics with breast cancer risk overall was similar for those with and without 
hormone receptor data (results not shown). The association with smoking before first birth 
differed by ER status, in which the association was stronger for risk of ER+ breast cancer than 
risk of ER- breast cancer (p-value for tumor heterogeneity=3x10-3). Modification of the 
associations of smoking initiation relative to first birth with breast cancer risk by alcohol intake 
also was stronger for risk of ER+ breast cancer (data not in tables). Current drinkers consuming 2 
or more drinks per day who smoked >10 years prior to first birth (HR=2.02, 95% CI 1.64 – 2.49) 




In this large pooled analysis, we addressed the key lingering epidemiologic issues raised in the 
2014 US Surgeon General’s report 11, including the importance of duration and timing of 
smoking initiation, the role of alcohol intake, modification by menopausal status, and differences 
in risk by ER status. We confirmed modest associations of current and former smoking with 
invasive breast cancer risk. We also showed that the timing of smoking initiation was the 
smoking characteristic most strongly associated with risk, with initiation more than 10 years 
before first birth associated with an 18% increased risk of breast cancer among parous ever 
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smokers, and was evident in non-drinkers and in every stratum of alcohol intake. Those who 
both initiated smoking more than 10 years before first birth and who were the heaviest drinkers 
(2 or more drinks per day) were at greatest risk from early smoking initiation (85% higher risk of 
breast cancer), compared to never smoking non-drinkers. Furthermore, this association was 
stronger for risk of ER+ breast cancer.  
 
Based on their meta-analysis of 22 case-control and prospective studies 11, the Surgeon General’s 
report concluded that the association for smoking before and after first birth did not differ. In our 
pooled analysis, we found a dose response with the number of years parous women smoked 
before their first birth. The association was evident in all strata of age at first birth and of 
duration of smoking indicating the association was independent of these factors, as previously 
suggested 11. The inconsistencies among prior studies might be due to the small number of cases, 
especially if examining the number of years of smoking prior to first birth, in individual studies 
and the recent maturity of prospective studies that included birth cohorts who initiated smoking 
at a young age. Our pooled analysis included six of the prospective studies included in the report 
11. Our results for initiation years before first birth are also consistent with models of 
carcinogenesis of the breast 19. 
 
We further addressed the concern of residual confounding effects by alcohol intake on the 
association of smoking with breast cancer risk 1, 2, 11-16 by using statistical control in 
multivariable models and by stratifying the association into categories of alcohol intake with 
additional statistical control for amount of alcohol within categories. Statistical control for 
alcohol intake at baseline only slightly attenuated the relative risks for smoking characteristics in 
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our study. Consistent with the Collaborative Group on Hormonal Factors in Breast Cancer 18, we 
observed no association between smoking status at baseline and breast cancer risk among non-
drinkers. However, we did observe associations with initiating smoking more than 10 years prior 
to first birth in non-drinkers and in every stratum of alcohol intake at baseline. We cannot, 
however, eliminate the possibility that this association is further confounded by alcohol 
consumption during early adult life, which was not captured by the majority of the studies in our 
analysis. In the Nurses’ Health Study II, women who had higher alcohol intake between 
menarche and first birth also reported higher intakes at baseline and after first pregnancy 
compared to women who abstained between menarche and first birth. In their multivariable 
analyses, alcohol intake before first birth, compared to those abstaining before first birth, was 
associated with breast cancer risk (per 10-g increase: HR=1.11, 95% CI 1.00 – 1.23), 
independent of cumulative alcohol intake after first pregnancy 24.  
 
Stronger associations between smoking and breast cancer in premenopausal women has been 
hypothesized because the morphology of the breast and endogenous hormone levels undergo 
significant changes during the menopausal transition and other breast cancer risk factors are 
modified by menopausal status 11. However, we found no modification by menopausal status, 
which is consistent with prior studies 25, 26. In our analysis, smoking initiation prior to first birth 
and smoking status were not modified by menopausal status. Although the interaction was 
statistically significant for duration of smoking in current smokers, the lower risk estimated for 
the women who had ≥40 years and who had not gone through menopause was based on very few 
cases (n=26) and the adjacent exposure category, women who smoked 20 – 39 years, did not 
differ across strata of menopause.  
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Despite initial published hypotheses and early evidence from small studies supporting a stronger 
association of smoking with ER- breast cancer 11, the findings from our pooled analysis suggest 
smoking, particularly initiation >10 years prior to first birth, suggest a positive association with 
risk of ER+, but not ER-, breast cancer. Although more recent data summarized in the report 
found stronger associations for ER+ breast cancer, they listed a number of limitations among the 
published studies, including use of case-control data, incomplete control for confounders, and 
bias due to incomplete assessment of ER status 11. Our pooled analysis was based on prospective 
cohort data, we controlled for a large number of known breast cancer risk factors, and we found 
no bias in the association with smoking among the cases who had ER status compared to those 
who did not. 
 
Although data pooling provided a large number of study participants, it also presented 
limitations. Variables were harmonized to be inclusive of all participating cohorts, and we were 
not able to harmonize all variables. We were not able to define a reference group that excluded 
passive smokers or lifelong never drinkers, which likely biased our results toward the null. 
Despite this limitation, we did not find evidence of between-study heterogeneity in the 
associations (Supplemental Figure 1 and 2). We only collected baseline data on smoking status 
and covariate information. Although current smokers at baseline may have quit during follow-up, 
one of the studies included here did not find differences in results of baseline or updated smoking 
status 20.  
 
Consistent with previous studies, our estimate of the magnitude of association between smoking 
status and breast cancer risk is modest. However, this association did not appear to be 
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confounded by alcohol intake, rather our results support a synergistic relationship between 
smoking initiation and adult alcohol drinking. Furthermore, we found that longer duration of 
smoking prior to first birth was associated with risk, and this association persisted in both 
drinkers and non-drinkers. The associations with smoking were more consistently associated 
with risk of ER+ breast cancer. Other lingering epidemiologic issues mentioned in the recent 
U.S. Surgeon General’s report do not appear to have a major influence. While the association 
with breast cancer might be modest relative to the more profound health effects of smoking on 
lung and other cancers, the number of breast cancer cases attributable to smoking might increase 
over time as the prevalence of adolescent smoking in U.S. has remained stable since the 1930s 27, 
28, and globally smoking initiation at young ages is increasing 29, and a greater proportion of 
women are delaying childbirth 30. Continued research in this area is warranted to further support 
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